Frontotemporal dementia trials in Poland

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)

  Where

  Katowice, Szczecin, Warsaw

  Age

  30 years to 75 years

  People

  18 worldwide

  Run by

  AviadoBio Ltd

  See details and how to joinNCT06064890 · EU 2023-509444-10-00